Naftopidil
CAS No. 57149-07-2
Naftopidil ( Naftopidil; BM-15275; KT-611; BM 15275; KT 611; BM15275; KT611; Flivas )
Catalog No. M15085 CAS No. 57149-07-2
Naftopidil (INN, marketed under the brand name Flivas) is an antihypertensive drug which acts as a selective α1-adrenergic receptor antagonist or alpha blocker.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 37 | In Stock |
|
1G | 59 | In Stock |
|
Biological Information
-
Product NameNaftopidil
-
NoteResearch use only, not for human use.
-
Brief DescriptionNaftopidil (INN, marketed under the brand name Flivas) is an antihypertensive drug which acts as a selective α1-adrenergic receptor antagonist or alpha blocker.
-
DescriptionNaftopidil (INN, marketed under the brand name Flivas) is an antihypertensive drug which acts as a selective α1-adrenergic receptor antagonist or alpha blocker.
-
SynonymsNaftopidil; BM-15275; KT-611; BM 15275; KT 611; BM15275; KT611; Flivas
-
PathwayEndocrinology/Hormones
-
TargetAdrenergic Receptor
-
Recptorα1A-adrenergic receptor; α1B-adrenergic receptor; α1D-adrenergic receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number57149-07-2
-
Formula Weight392.49
-
Molecular FormulaC24H28N2O3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 79 mg/mL (201.27 mM)
-
SMILESOC(COC1=C2C=CC=CC2=CC=C1)CN3CCN(C4=CC=CC=C4OC)CC3
-
Chemical Name1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sakai H, et al. Hinyokika Kiyo. 2011 Jan;57(1):7-13.
molnova catalog
related products
-
Nadolol
A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension.
-
Phentolamine mesilat...
Phentolamine Mesylate is a nonselective alpha-adrenergic antagonist.
-
Buflomedil hydrochlo...
Buflomedil hydrochloride is a vasodilator used to treat claudication or the symptoms of peripheral arterial disease.